Cellero Expands Diabetes-Related Products with Anti-GAD65 T Cells
Following the successful and anticipated launch of our Anti-ProInsulin T Cells for PI-1 and PI-3 last year, researchers like you have asked us to develop additional antigen-specific T cell lines for diabetes research. We are excited to announce our latest cell line for diabetes autoimmunity research, the Anti-GAD65 T Cells! View Anti-GAD65 T Cells Lot…